Impact of Pain and Symptom Burden on the Health-related Quality of Life of Hemodialysis Patients
Overview
Pharmacology
Psychiatry
Authors
Affiliations
Context: Dialysis patients experience tremendous symptom burden and substantial impaired health-related quality of life (HRQL).
Objectives: We determined the association between symptom burden and HRQL in 591 hemodialysis patients.
Methods: Patients completed the modified Edmonton Symptom Assessment System and the Kidney Dialysis Quality of Life Short Form at baseline and after six months.
Results: There were no demographic, serological, or dialysis-related predictors for either HRQL or symptom burden. Pain, tiredness, lack of well-being, and depression were the only independent predictors of mental HRQL, accounting for 42.5% of the variation in the baseline mental health composite (MHC). Pain, fatigue, lack of well-being, and shortness of breath were the only independent predictors of physical HRQL, accounting for 38.5% of the variation in the baseline physical health composite (PHC). After follow-up, only changes in depression, anxiety, tiredness, and lack of appetite were independently associated with a change in MHC score, accounting for 48.7% of the variability. Only changes in pain, tiredness, and lack of appetite were independently associated with a change in PHC, accounting for 44.6% of the variability in the final multivariate regression model. No change in biochemical parameters predicted a change in either the MHC or the PHC.
Conclusion: Symptom burden in end-stage renal disease was substantial and had a tremendous negative impact on all aspects of hemodialysis patients' HRQL. These patients, therefore, would likely benefit from the institution of programs to reduce symptom burden.
Chen J, Johnson D, Roberts M, Brown M, Brennan F, Wong G Clin Kidney J. 2025; 18(3):sfaf024.
PMID: 40046820 PMC: 11879430. DOI: 10.1093/ckj/sfaf024.
Scherer J, Wu W, Lyu C, Goldfeld K, Brody A, Chodosh J Contemp Clin Trials Commun. 2025; 44:101439.
PMID: 40008278 PMC: 11851192. DOI: 10.1016/j.conctc.2025.101439.
Implementation of Ambulatory Kidney Supportive Care in a Safety Net Hospital.
Scherer J, Gore R, Georgia A, Cohen S, Caplin N, Zhadanova O J Pain Symptom Manage. 2025; 69(4):e272-e282.
PMID: 39788301 PMC: 11867855. DOI: 10.1016/j.jpainsymman.2024.12.025.
The Choice of Anti-Inflammatory Influences the Elimination of Protein-Bound Uremic Toxins.
Escudero-Saiz V, Cuadrado-Payan E, Rodriguez-Garcia M, Casals G, Rodas L, Fontsere N Toxins (Basel). 2024; 16(12).
PMID: 39728803 PMC: 11679929. DOI: 10.3390/toxins16120545.
Renal Disease in Cats and Dogs-Lessons Learned from Text-Mined Trends in Humans.
Dadousis C, Whetton A, Mwacalimba K, Merlo A, Wright A, Geifman N Animals (Basel). 2024; 14(23).
PMID: 39682316 PMC: 11639467. DOI: 10.3390/ani14233349.